George Yancopoulos, Regeneron president and CSO (Regeneron)

Re­gen­eron scores la­bel ex­pan­sion for cho­les­terol drug Evkeeza

Re­gen­eron’s drug for a rare dis­ease that caus­es high cho­les­terol has been ex­pand­ed to in­clude chil­dren ages 5 to 11 years old af­ter an …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA